Gesynta Pharma AB is a company that provides Oral treatment, Biomedicine, Biotechnology and more. Gesynta Pharma AB is headquartered in Sweden . Gesynta Pharma AB was founded in 2017. Gesynta Pharma AB has a total of 42 patents
Gesynta Pharma's most advanced drug candidate GS-248 is in clinical phase II development for the treatment of endometriosis – a painful, chronic inflammatory...